Answers are grounded in this paper and cite their sources.
Evaluates integrated wastewater treatment, highlighting cost-effectiveness and high mineralization efficiency.
This study presents an integrated approach for treating synthetic pharmaceutical wastewater (SPWW) using adsorption on activated carbon (AC), in situ steam regeneration, and oxidation of steam condensate by a UV/H2O2 process. Experiments were conducted in the fixed bed columns to evaluate the effects of flow rate (0.5–2 L min–1) and inlet total organic carbon (TOCin = 400 or 1000 mgC L–1) on adsorption performance. Breakthrough behavior was modeled using a one-dimensional advection–dispersion equation with a linear driving force (LDF), allowing the estimation of mass transfer parameters and the column efficiency. Under optimal adsorption conditions (TOCin = 400 mgC L–1, T = 23 ± 3 °C, and Q = 0.5 L min–1), 210 L of wastewater was treated with 55% bed utilization at the breakthrough point. Steam regeneration (140–180 °C; 0.26–0.89 L min–1) achieved up to 74% capacity recovery while concentrating contaminants into a 17 L condensate, reducing wastewater volume by 92% before the UV/H2O2 treatment stage. Overall, the reduction in fresh carbon demand due to regeneration and the significant decrease in wastewater volume requiring advanced oxidation resulted in a minimized operational cost of $159/m3. The subsequent UV/H2O2 treatment also achieved 69% TOC mineralization (HRT = 60 min and H2O2/TOC = 4 mg/mg), effectively treating the concentrated condensate and supporting the technical and economic viability of the integrated process.
No takes yet. Share an insight, caveat, or question.
Asheghmoalla et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: